Insider Trading & SAST disclosures for Krebs Biochemicals & Industries Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
IPCA LABORATORIES LIMITED in Krebs Biochemicals & Industries Ltd. where Acquisition of 1,620,000
Equity Shares done at an average price of Rs. 86
was reported to the exchange on Sept. 14, 2020.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Ipca Laboratories Ltd in Krebs Biochemicals & Industries Ltd. where Acquisition of 1,940,000
shares done
was reported to the exchange on April 6, 2021.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
Ipca Laboratories Ltd
|
Promoter |
Acquisition |
07 Apr 2021 |
1,940,000 |
10,705,195
(49.65%)
|
9%
|
|
-
|
06 Apr 2021 06 Apr 2021 |
SAST (29(2)) |
- |
Pref. Allotment |
IPCA LABORATORIES LIMITED
|
Promoter |
Acquisition |
14 Sep 2020 |
1,620,000 |
8,765,195
(44.67%)
|
8.26%
|
86 |
139,320,000
|
20 May 2020 20 May 2020 |
Insider Trading |
Equity Shares |
Allotment |
Ipca Laboratories Ltd
|
Promoter |
Acquisition |
20 May 2020 |
1,620,000 |
8,765,195
(44.67%)
|
4.98%
|
|
-
|
20 May 2020 20 May 2020 |
SAST (29(2)) |
- |
Pref. Allotment |
IPCA LABORATORIES LIMITEDAAACI1220M
|
Promoter |
Acquisition |
06 Feb 2020 |
1,370,000 |
7,145,195
(39.69%)
|
8.24%
|
86 |
117,820,000
|
05 Feb 2020 05 Feb 2020 |
Insider Trading |
Equity Shares |
Preferential Offer |
Ipca Laboratories Ltd
|
Promoter |
Acquisition |
06 Feb 2020 |
1,370,000 |
7,145,195
(39.69%)
|
7.61%
|
|
-
|
05 Feb 2020 05 Feb 2020 |
SAST (29(2)) |
- |
Pref. Allotment |
Mr Avinash Ravi
|
Promoter |
Others |
24 Dec 2024 |
200,000 |
0
|
-
|
|
-
|
04 Nov 2019 04 Nov 2019 |
SAST (Reg31) |
- |
Release |
Mrs Hemalata Ravi
|
Promoter |
Others |
24 Dec 2024 |
200,000 |
0
|
-
|
|
-
|
04 Nov 2019 04 Nov 2019 |
SAST (Reg31) |
- |
Release |
Mrs Hemalata Ravi
|
Promoter |
Others |
24 Dec 2024 |
200,000 |
0
|
-
|
|
-
|
04 Nov 2019 04 Nov 2019 |
SAST (Reg31) |
- |
Release |
Mr Avinash ravi
|
Promoter |
Others |
24 Dec 2024 |
200,000 |
0
|
-
|
|
-
|
04 Nov 2019 04 Nov 2019 |
SAST (Reg31) |
- |
Release |
Ajay Ravi
|
Promoters Immediate Relative |
Acquisition |
02 Apr 2019 |
19,488 |
112,288
(0.67%)
|
0.14%
|
86 |
1,675,968
|
28 Mar 2019 28 Mar 2019 |
Insider Trading |
Equity Shares |
Allotment |
Ipca Laboratories Limited
|
Promoter |
Acquisition |
01 Apr 2019 |
1,675,095 |
5,775,195
(34.73%)
|
12.19%
|
86 |
144,058,170
|
26 Mar 2019 26 Mar 2019 |
Insider Trading |
Equity Shares |
Allotment |
Avinash Ravi
|
Promoter & Director |
Acquisition |
01 Apr 2019 |
371,451 |
2,140,272
(12.87%)
|
2.70%
|
86 |
31,944,786
|
28 Mar 2019 28 Mar 2019 |
Insider Trading |
Equity Shares |
Allotment |
Hemalata Ravi
|
Promoter |
Acquisition |
01 Apr 2019 |
467,124 |
2,691,524
(16.18%)
|
3.40%
|
86 |
40,172,664
|
28 Mar 2019 28 Mar 2019 |
Insider Trading |
Equity Shares |
Allotment |
Avinash Ravi & PAC
|
Promoter |
Acquisition |
29 Mar 2019 |
863,989 |
4,978,230
(29.93%)
|
5.20%
|
|
-
|
28 Mar 2019 28 Mar 2019 |
SAST (29(2)) |
- |
Rights Issue |
Ipca Laboratories Ltd
|
Promoter |
Acquisition |
27 Mar 2019 |
1,675,095 |
5,775,195
(34.73%)
|
10.07%
|
|
-
|
26 Mar 2019 26 Mar 2019 |
SAST (29(2)) |
- |
Rights Issue |
Dr R T Ravi
|
Promoter |
Disposal |
04 Oct 2017 |
179,316 |
19,400
(0.14%)
|
1.30%
|
|
-
|
22 Sep 2017 22 Sep 2017 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
Avinash Ravi
|
Promoter |
Acquisition |
04 Oct 2017 |
179,316 |
1,768,821
(12.87%)
|
1.30%
|
|
-
|
22 Sep 2017 22 Sep 2017 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
Avinash Ravi
|
Promoter |
Acquisition |
24 Nov 2015 |
3,500 |
1,586,905
(12.15%)
|
0.03%
|
130 |
455,000
|
20 Nov 2015 20 Nov 2015 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
Avinash Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
1,230,000 |
200,000
|
-
|
|
-
|
16 Nov 2015 16 Nov 2015 |
SAST (Reg31) |
- |
Release |
Ajay Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
85,000 |
0
|
-
|
|
-
|
16 Nov 2015 16 Nov 2015 |
SAST (Reg31) |
- |
Release |
Hemalata Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
685,000 |
200,000
|
-
|
|
-
|
16 Nov 2015 16 Nov 2015 |
SAST (Reg31) |
- |
Release |
Avinash Ravi
|
Promoter |
Acquisition |
04 Nov 2015 |
35,000 |
1,583,405
(12.12%)
|
0.25%
|
130 |
4,550,000
|
30 Oct 2015 30 Oct 2015 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
Mohd. Vahidullah
|
Promoter |
Disposal |
04 Nov 2015 |
10,000 |
-
|
0.07%
|
130 |
1,300,000
|
30 Oct 2015 30 Oct 2015 |
Insider Trading |
Equity Shares |
Off Market / Inter se transfer |
Samba Siva Rao Ravi
|
Promoter |
Disposal |
04 Nov 2015 |
25,000 |
-
|
0.18%
|
130 |
3,250,000
|
30 Oct 2015 30 Oct 2015 |
Insider Trading |
Equity Shares |
Off Market / Inter se transfer |
Mrs Hemalata Ravi
|
Promoter |
Acquisition |
09 Oct 2015 |
680,000 |
680,000
(4.95%)
|
4.95%
|
|
-
|
|
Insider Trading |
Equity Shares |
Pref. Allotment |
Hemalata Ravi
|
Promoter |
Acquisition |
09 Oct 2015 |
650,000 |
1,544,400
(11.82%)
|
4.73%
|
|
-
|
03 Oct 2015 03 Oct 2015 |
Insider Trading |
Equity Shares |
Pref. Allotment |
Mrs. Hemalata Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
200,000 |
885,000
|
-
|
|
-
|
20 Aug 2015 20 Aug 2015 |
SAST (Reg31) |
- |
Creation |
Mr. Avinash Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
200,000 |
1,430,000
|
-
|
|
-
|
11 Aug 2015 11 Aug 2015 |
SAST (Reg31) |
- |
Creation |
Mrs. Hemalata Ravi
|
Promoter |
Pledge |
24 Dec 2024 |
208,400 |
685,000
|
-
|
|
-
|
07 Jul 2015 07 Jul 2015 |
SAST (Reg31) |
- |
Release |
Ipca Laboratories Ltd
|
Promoter |
Acquisition |
11 May 2015 |
2,300,000 |
4,100,000
(33.03%)
|
18.53%
|
|
-
|
09 May 2015 09 May 2015 |
SAST (29(2)) |
- |
Pref. Allotment |
Ipca Laboratories Ltd
|
Other |
Acquisition |
13 Feb 2015 |
1,800,000 |
1,800,000
(18.92%)
|
18.92%
|
|
-
|
11 Feb 2015 11 Feb 2015 |
SAST (29(1)) |
- |
Market |
Ipca Laboratories Ltd
|
Other |
Acquisition |
12 Feb 2015 |
1,800,000 |
1,800,000
(18.92%)
|
18.92%
|
|
-
|
11 Feb 2015 11 Feb 2015 |
SAST (29(1)) |
- |
Off Market |
Avinash Ravi
|
Promoter |
Disposal |
12 Feb 2015 |
150,000 |
1,548,304
(16.27%)
|
1.57%
|
|
-
|
11 Feb 2015 11 Feb 2015 |
SAST (29(2)) |
- |
Off Market |
Ajay Ravi
|
Promoter |
Disposal |
12 Feb 2015 |
540,000 |
92,800
(0.97%)
|
5.68%
|
|
-
|
11 Feb 2015 11 Feb 2015 |
SAST (29(2)) |
- |
Off Market |
Aditya Ravi
|
Promoter |
Disposal |
12 Feb 2015 |
1,110,000 |
8,820
(0.10%)
|
11.67%
|
|
-
|
11 Feb 2015 11 Feb 2015 |
SAST (29(2)) |
- |
Off Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.